AFT gets first step of US approval for Maxigesic IV

Sophie Boot
Wed, 23 Mar 2016

By Sophie Boot March 24 (BusinessDesk) - AFT Pharmaceuticals has crossed the first hurdle in getting the intravenous version of its patented combination painkiller Maxigesic approved by the US Food and Drug Administration. The investigational new drug application (IND) for Maxigesic IV has been approved by the FDA, which is the first step towards getting approval in the US, the Auckland-based drugmaker said in a statement. It will now conduct a clinical study in Christchurch, followed by one in the US, as part of the path to gaining appro...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Law & Regulation
Juice magnate Lepionka sues lawyers for 'negligent' advice
Greg Hurrell | Tue, 05 Jul 2022

Businessman Stefan Lepionka's negligence case against Gibson Sheat will be split in two, with the law firm's countersuit to be heard first, the high court has ruled.

George Kerr's Pyne Gould receivership continues
Victoria Young | Tue, 05 Jul 2022

Court action continues in the UK, while receivers have already clawed back $8m for the BNZ by selling South Island land.

Don’t cut off Māori landowners’ forest options
Te Kapunga Dewes | Tue, 05 Jul 2022

Well-intentioned academic and environmental critics of exotic forest planting are standing in the way of one of the few economic opportunities available for the use of marginal Māori land.

How can Kiwi small business owners manage rising inflation?

Xero MD Craig Hudson says small businesses have been hit with a triple whammy.

Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges